Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Cardura. Always confirm against the full prescribing information.
100 interactions
Abatacept
The metabolism of Doxazosin can be increased when combined with Abatacept.
Level 1 evidence
Abemaciclib
The metabolism of Abemaciclib can be decreased when combined with Doxazosin.
Level 2 evidence
Abiraterone
The metabolism of Doxazosin can be decreased when combined with Abiraterone.
Level 1 evidence
Abrocitinib
The metabolism of Abrocitinib can be decreased when combined with Doxazosin.
Level 2 evidence
Acalabrutinib
The metabolism of Acalabrutinib can be decreased when combined with Doxazosin.
Level 2 evidence
Acebutolol
Acebutolol may increase the orthostatic hypotensive activities of Doxazosin.
Level 2 evidence
Aceclofenac
The therapeutic efficacy of Doxazosin can be decreased when used in combination with Aceclofenac.
Level 2 evidence
Acenocoumarol
The metabolism of Acenocoumarol can be decreased when combined with Doxazosin.
Level 2 evidence
Acetaminophen
The metabolism of Doxazosin can be increased when combined with Acetaminophen.
Level 2 evidence
Acetazolamide
The metabolism of Doxazosin can be decreased when combined with Acetazolamide.
Level 2 evidence
Acetylcholine
The risk or severity of adverse effects can be increased when Doxazosin is combined with Acetylcholine.
Level 2 evidence
Acoramidis
The metabolism of Doxazosin can be decreased when combined with Acoramidis.
Level 2 evidence
Enter your NPI to unlock 6 major interactions for Cardura
Cardura (Doxazosin Mesylate) has 999 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Cardura (Doxazosin Mesylate) has 63 major, 529 moderate, and 407 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Cardura. Always confirm against the full prescribing information.